AUTHOR LISTING OF COMPREHENSIVE RELATIONSHIPS WITH INDUSTRY AND OTHERS

Size: px

Start display at page:

Download "AUTHOR LISTING OF COMPREHENSIVE RELATIONSHIPS WITH INDUSTRY AND OTHERS"

Stanley Hicks
6 years ago
Views:

1 2013 ACCF/AHA Guideline for the Management of Heart Failure ONLINE AUTHOR LISTING OF COMPREHENSIVE RELATIONSHIPS WITH INDUSTRY AND OTHERS (May 2013) Member Employment Consultant Speaker s Bureau Personal Research Clyde W. Yancy, Chair Mariell Jessup, Vice Chair Biykem Bozkurt Javed Butler Donald E. Casey, Jr. Northwestern University Chief, Division of and Magerstadt Professor of Pennsylvania Professor of Michael E. DeBakey VA Medical Center The Mary and Gordon Cain Chair and Professor of Emory Healthcare Director of Heart Failure Research; Emory University School of Professor of Clinically Integrated Physician Network, NYU Langone Medical Center Vice President and Medical Director Ownership/ Partnership/ Principal Institutional, Organizational or Other Financial Benefit AHA Amgen Celladon HeartWare AHA HFSA NIH* Amgen Corthera NIH Novartis Amgen Biotronic Cardiomems Corthera FoldRx icoapsys NIH* Johnson & Johnson ASCEND-HF Rule 90 Thoratec World Heart Inc. Expert Witness American College of Foundation and American Heart Association, Inc.

2 Mark H. Drazner Gregg C. Fonarow Stephen A. Geraci Tamara Horwich James L. Januzzi Maryl R. Johnson Texas Southwestern Medical Center Professor, Internal Director Ahmanson UCLA Cardiomyopathy Center; Co-Chief UCLA Division of Quillen College of /East Tennessee State University Chairman of Internal Ahmanson UCLA Cardiomyopathy Center Assistant Harvard Medical School Associate Professor of ; Massachusetts General Hospital Director, Cardiac Intensive Care Unit Wisconsin Madison Director, Heart Failure Optum Health HeartWare NIH/NHLBI* Novartis* NHLBI* (Co-I) Novartis* American Heart Journal Journal of Cardiac Failure Thoratec* ACCF/AHA Data Standards ACTION Registry GWTG Steering Chair GWTG Steering IMPROVE HF EP Dynamics* NHLBI* Iris Cantor-UCLA Women s Health Center UCLA Clinical and Transitional Science Institute* Critical Roche CareMark Transmedics (Clinical Trials ) Critical Dade-Boehring/ Siemens* Roche American Society of Transplantation- Current President NIH Heart Failure American College of Foundation and American Heart Association, Inc.

3 Edward K. Kasper Wayne C. Levy Frederick A. Masoudi Patrick E. McBride John J. V. McMurray and Transplantation Johns Hopkins Hospital E. Cowles Andrus Professor in Director, Clinical Washington Professor of, Division of Colorado, Denver Associate Division of Wisconsin School of and Public Health Professor of and Family, Associate Dean for Students, Associate Director, Preventive Glasgow, Scotland, BHF Glasgow Cardiovascular Research Center Professor of Clinical Trials Network (DSMB) UNOS Thoracic Organ Boehringer Ingelheim Cardiac Dimensions* Thomson Reuters GlaxoSmithKli ne Amgen RED-HF HeartWare* NIH-DCRI Amgen RED- HF* CardioMems CHAMPION Epocrates General Electric Johnson & Johnson/Scios ASCEND HF Axio Research* ACC* AHA AHRQ Massachusetts Medical Society NHLBI* Oklahoma Foundation for Medical Quality* NIH-NIDDK LOOK AHEAD (DSMB) GlaxoSmithKline* Novartis Oxford/Duke University Novartis ALTITUDE/ PARADIGM-HF American College of Foundation and American Heart Association, Inc.

4 Judith E. Mitchell Pamela N. Peterson Barbara Riegel Flora Sam Lynne W. Stevenson W.H. Wilson Tang Medical SUNY Downstate Medical Center Director, Heart Failure Center; Associate Professor of Colorado, Denver Health Medical Center Associate Division of Pennsylvania School of Nursing Professor Boston University School of, Whitaker Cardiovascular Institute Associate Professor of, Division of / Cardiomyopathy Program Brigham and Women s Hospital Cardiovascular Division Director, Cardiomyopathy and Heart Failure Program Cleveland Clinic Foundation Associate Research Director for Heart Failure/Transplant EXSCEL (DSMB) Oxford/Duke University TECOS (DSMB) Roche ALECARDIO (DSMB) NHLBI PRIDE AHA NIH (PI)* NHLBI NHLBI INTERMACS St. Jude Medical* NIH* Abbott Laboratories Asahi Kasei FoldRx St. Jude Medical Circulation Heart Failure (Senior Associate Editor) Emily J. Tsai Temple University School AHA Scientist HFSA American College of Foundation and American Heart Association, Inc.

5 of Assistant Bruce L. Wilkoff Cleveland Clinic Director, Cardiac Pacing and Tachyarrhythmia Devices; Director, Clinical EP Research Development Grant* NIH* NHLBI Biotronic Boston Scientific St. Jude Medical This table represents all healthcare relationships of committee members with industry and other entities that were reported by authors, including those not deemed to be relevant to this document, at the time this document was under development. The table does not necessarily reflect relationships with industry at the time of publication. A person is deemed to have a significant interest in a business if the interest represents ownership of 5% of the voting stock or share of the business entity, or ownership of $ of the fair market value of the business entity; or if funds received by the person from the business entity exceed 5% of the person s gross income for the previous year. Relationships that exist with no financial benefit are also included for the purpose of transparency. Relationships in this table are modest unless otherwise noted. Please refer to Quality/Practice-Guidelines-and-Quality-Standards/Relationships-With-Industry-Policy.aspx for definitions of disclosure categories or additional information about the ACCF/AHA Disclosure Policy for Writing s. *Indicates significant relationship. No financial benefit. ACC indicates American College of ; AHA, American Heart Association; AHEAD, Action For Health in Diabetes; AHRQ, Agency for Healthcare Research & Quality; ALECARDIO, Cardiovascular Outcomes Study to Evaluate the Potential of Aleglitazar to Reduce Cardiovascular Risk in Patients With a Recent Acute Coronary Syndrome Event and Type 2 Diabetes Mellitus; ALTITUDE, Aliskiren Trial in Type 2 Diabetes Using Cardio-Renal Endpoints; ASCEND-HF, Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure; CHAMPION, CardioMEMS Heart Sensor Allows Monitoring of Pressure to Improve Outcomes in NYHA Class III Patients; DCRI, Department of Clinical Research Informatics; DSMB, Data Safety Monitoring Board; EP, electrophysiology; EXSCEL, Exenatide Study of Cardiovascular Event Lowering; GWTG, Get With The Guidelines; HF, heart failure; HFSA, Heart Failure Society of America; IMPROVE HF, Registry to Improve the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting; INTERMACS, Interagency Registry for Mechanically Assisted Circulatory Support; NHLBI, National Heart, Lung, and Blood Institute; NIDDK, National Institute of Diabetes and Digestive and Kidney Diseases; NIH, National Institute of Health; NYU, New York University; PARADIGM-HF, Prospective Comparison of ARNI With ACEI to Determine Impact on Global Mortality and Morbidity in Patients With Heart Failure; PRIDE, Prolonging Remission in Depressed Elderly; SUNY, State New York; TECOS, Trial Evaluating Cardiovascular Outcomes with Sitagliptin in Patients with Type 2 Diabetes; UCLA, California, Los Angeles; UNOS, United Network for Organ Sharing; and VA, veterans affairs. American College of Foundation and American Heart Association, Inc.

2013 ACCF/AHA Guideline for the Management of Heart Failure COPYRIGHT

2013 ACCF/AHA Guideline for the Management of Heart Failure by Clyde W. Yancy, Mariell Jessup, Biykem Bozkurt, Javed Butler, Donald E. Casey, Mark H. Drazner, Gregg C. Fonarow, Stephen A. Geraci, Tamara